Navigation Links
Medivation to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference
Date:5/13/2009

SAN FRANCISCO, May 13 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that David Hung, M.D., president and chief executive officer, will present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference on Wednesday, May 20 in New York.

Dr. Hung will provide an overview of Medivation and its clinical development programs at 10:30 a.m. Eastern Time, which will be webcast. In addition, Dr. Hung will participate in an expert panel discussion titled, "New Developments in Solid Tumors, Focusing on GU and GI Cancers," on the same day at 8:10 a.m. Eastern Time.

A live audio webcast of the corporate presentation will be available on the "Events and Presentations" page of the "Investor Relations" section of the Company's website at http://www.medivation.com. A replay also will be available for 30 days following the live presentation.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation announced a global agreement with Pfizer Inc to develop and commercialize Dimebon for the treatment of Alzheimer's and Huntington's diseases. With Pfizer, the Company is conducting a broad Dimebon clinical development program, including a pivotal and confirmatory Phase 3 trial, known as the CONNECTION study, in patients with mild-to-moderate Alzheimer's disease. The program also includes additional trials planned to begin this year in Alzheimer's disease, as well as further
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Medivation Reports First Quarter 2009 Financial Results and Provides Corporate Update
2. Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer
3. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
4. Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients
5. Medivation Announces Participation in Upcoming Conferences
6. Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference
7. Medivation Announces Participation in Upcoming Conferences
8. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference
9. Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimers Disease in Second Quarter of 2008
10. Medivation to Announce Early Positive Data from Phase 1-2 Hormone Refractory Prostate Cancer Trial and Host Conference Call and Webcast on Monday, November 5, 2007
11. Genomic Health to Present at JMP Securities Research Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... "I recognized the need for a better ... an inventor from Cincinnati, Ohio. "This need inspired me ... the Slyde Door to offer an alternative to the ... provides convenient storage space for an evacuation stretcher. The ... patients. , This offers added peace of mind ...
(Date:4/18/2015)... 2015 Lower-auto-insurance.com has released a new ... auto insurance quotes . , Drivers can find ... quotes. A professional insurance brokerage website can help drivers ... a simple, convenient way. The whole process is designed ... , Comparing online car insurance quotes is advantageous because ...
(Date:4/18/2015)... 2015 On April 14th, 2015, Symantec released ... which they say, “exposes a tactical shift by cyberattackers.” With ... were introduced in 2014 - almost a million a day ... to be identified and patched by prominent manufacturers – as ... doing business in a digital world can be fraught with ...
(Date:4/17/2015)... April 18, 2015 Heritage Woods of ... its Supportive Living Week Celebration on April 20 with ... a healthy mind, body and soul. , The community, ... Illinois, serves older adults of all incomes, including those ... independence. , Supportive Living Week is observed every April ...
(Date:4/17/2015)... 2015 Alcohol and Violence , The ... that drinking and driving has been the focus of ... time, the link between alcohol and crime received less ... violence and sexual assault, and their relationship to alcohol ... 5.3 million adults in America were drinking alcohol at ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3
... Financial Services Are Adding Jobs WACO, Texas, March 6 ... , the world leader in employment evaluation and human ... job sectors that continue to hire despite the latest ... clients that continue to seek talent," said Jim Sirbasku, ...
... study finds 95% of headsets contaminated with bacteria ... (HealthDay News) -- A new culprit has emerged ... and other infections in hospitals -- mobile phone ... doctors and nurses working in hospitals found that ...
... to announce the signing of UFC Heavyweight Shane Carwin. Muscle ... Carwin."We are very excited about adding Shane to our team. ... Brad Pyatt, Muscle Pharm President. Shane Carwin is a rising ... professional fight of his career March 7th against Gabriel Gonzaga. ...
... Workforce Prescriptions ("WRX") announced on Friday that it would ... to bring relief to thousands of hospitals previously not ... has spent the last 3 years working primarily with ... having to resort to reductions in staff or services.Through ...
... Cooperative Offers Up Delicious Recipes and Sage Advice ... is National Nutrition Month. In support of the ... on the importance of making informed food choices ... Cabot Creamery Cooperative has developed a host of ...
... 2009 Forest Laboratories, Inc. (NYSE: FRX ) ... today that they expect to ship Savella(TM) (milnacipran HCl), a ... fibromyalgia, to wholesalers and pharmacies by mid 2009. Savella ... (FDA) on January 14, 2009 and was originally expected to ...
Cached Medicine News:Health News:Unemployment Rises, Profiles International Reveals Who's Hiring 2Health News:WRX Expands Nationally to Provide Help & Hope to Nation's Hospitals 2Health News:Photo: March Forth Into Spring with a Healthy Approach to Diet and Exercise 2Health News:Photo: March Forth Into Spring with a Healthy Approach to Diet and Exercise 3Health News:Photo: March Forth Into Spring with a Healthy Approach to Diet and Exercise 4Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 2Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 3Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 4Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 5Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 6
(Date:4/17/2015)... , April 17, 2015 ... leading Life Science and High Technology company, today ... Pacific headquarters and state-of-the-art Cell Culture ... Park, the facility will provide customized support to ... scientific capabilities. "Our new Technical Center ...
(Date:4/16/2015)... , April 16, 2015 Vanda Pharmaceuticals ... focused on the development and commercialization of products for ... it will release results for the first quarter of ... closes. The Company will host a ... 6, 2015, during which Vanda management will discuss the ...
(Date:4/16/2015)... 16, 2015  Hologic, Inc. (NASDAQ: HOLX ... study i published on-line this week in ... the American Cancer Society. The study, ... Pittsburgh Medical Center, supports current consensus guidelines ii ... 30-65 years of age be co-tested with both ...
Breaking Medicine Technology:Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 2Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 3Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 4Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 5Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4
... FALLS CHURCH, Va., Oct. 23 -- Today the ... General of the United States Agency for,International Development ... violating federal law by funding nonprofit groups operating,needle ... Organizations affiliated with billionaire political activist George,Soros ...
... Hemodynamics and Delay Disease Progression -, CHICAGO, ... positive results from two trials demonstrating that,Tracleer(R) (bosentan) ... therapy,for the treatment of pulmonary arterial hypertension (PAH). ... in combination with sildenafil,is well-tolerated and improves hemodynamics ...
Cached Medicine Technology:Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups 2Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 2Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: